9th Annual MarketsandMarkets

High Potent Medicines Conference - EU Edition

22nd - 24th May 2024

NH Milano Congress Centre. Strada 2, 7, 20057 Assago MI, Italy

Avail Your Ticket Avail
Your Ticket
Become A Sponsor Become
A Sponsor
Become A Speaker Become
A Speaker

EVENT OVERVIEW

Welcome to the MarketsandMarkets 9th High Potent Medicines Conference– the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). This transformative event converges industry leaders and regulatory professionals on a singular platform dedicated to exploring cutting-edge developments in the development, manufacturing, and safe handling of highly potent compounds.

Engage with real-world experiences and case studies from companies at the forefront of successful HPAPI programs. Learn from challenges, uncover best practices and pioneering strategies in containment technologies, risk assessment, and occupational health and safety that are shaping the industry's approach to safety, quality control, and regulatory compliance in effective HPAPI manufacturing.

WHAT TO EXPECT

  • Technology transfer and scale up of HPAPI’s
  • Right CDMO selection and partnership
  • Containment and handling of HPAPI’s
  • Cleaning validation and risk mitigation
  • Regulatory landscape and compliance
  • Occupational Health and Safety

  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

 

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer
  • Environmental, Health & Safety (HSE)
  • Occupational Toxicology
  • Industrial Hygiene
  • New Products
  • Product Quality
  • Regulatory
  • Validation
  • Formulation Development

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by